Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy alternatives remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Take a look https://financefeeds.com/iosco-publishes-2025-work-program-and-report-on-ai/